newsfilter
← Latest News
GlobeNewswire·

Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

JUPITER, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026.